Diagnosing cancer, pregnancy complications

Diagnosing cancer or pregnancy complications
© Thinkstock

Based on their previous discovery of progesterone-induced blocking factor (PIBF), European scientists have developed a diagnostic assay that could be used to detect pregnancy complications or cancer.

PIBF is a required for maintaining a normal pregnancy. PIBF levels in the urine and blood of healthy pregnant women increase during pregnancy and decrease rapidly during delivery.

Previous work had shown that PIBF levels in women with were significantly lower, and demonstrated that PIBF blocks the autoimmune response which normally leads to the killing of rapidly growing fetal tissue.

Surprisingly, high levels of PIBF have been detected in , suggesting that it constitutes an essential marker for their discovery. The EU-funded PIBF proposal planned to develop a novel testing assay to diagnose malignant tumours, monitor tumour therapy and diagnose premature abortion risk.

Project scientists developed and validated an enzyme-linked immuno sorbent assay (ELISA) for measuring PIBF protein in biological fluids. Although the assay presented with limited sensitivity and precision due to the of the tested protein, it exhibited great reproducibility, making it ideal for inter-laboratory testing.

GMP grade reagents were also produced for the application of the assay in a clinical setting. Studies on clinical samples confirmed the potential role of PIBF in certain pathological pregnancies, and the elevated expression of PIBF in certain cancer patients.

However, similarly to other marketed tumour marker tests, the PIBF ELISA alone did not provide sufficient specificity and sensitivity to be used as a single screening . The developers of this kit are nonetheless hopeful that in combination with other diagnostic tests, this assay will contribute to the higher diagnostic standards of pathological pregnancies and malignant tumours.

add to favorites email to friend print save as pdf

Related Stories

New biomarker may help diagnose ectopic pregnancies

Nov 04, 2010

Researchers may have identified a promising novel diagnostic biomarker for ectopic pregnancy, according to a study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) ...

New technology sheds light on viruses

Apr 10, 2012

(Phys.org) -- Diagnostic tests that rapidly detect disease-causing viruses in animals and humans are being developed by U.S. Department of Agriculture (USDA) scientists using a new technology called "surface-enhanced ...

Recommended for you

Growing a blood vessel in a week

Oct 24, 2014

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

Oct 24, 2014

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments